nad has been researched along with Drug-Induced Cochlear Toxicity in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 2 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, Z; Dong, H; Fang, J; Mao, S; Shi, H; Su, K; Wu, H; Xing, Y; Yu, D; Zhang, J | 1 |
| Gao, Y; He, F; He, W; Huang, X; Jian, B; Liang, Z; Min, X; Pang, J; Xiong, H; Yang, H; Ye, Y; Zhan, T; Zhang, W; Zheng, Y | 1 |
2 other study(ies) available for nad and Drug-Induced Cochlear Toxicity
| Article | Year |
|---|---|
A reduced form of nicotinamide riboside protects the cochlea against aminoglycoside-induced ototoxicity by SIRT1 activation.
Topics: 14-3-3 Proteins; Aminoglycosides; Animals; Anti-Bacterial Agents; Cochlea; Hearing Loss; Kanamycin; Mice; NAD; Niacinamide; Ototoxicity; Pyridinium Compounds; Reactive Oxygen Species; Resveratrol; Sirtuin 1 | 2022 |
Modulation of NAD
Topics: Animals; Animals, Genetically Modified; Carboxy-Lyases; Cisplatin; Disease Models, Animal; Enzyme Activation; Enzyme Inhibitors; Hair Cells, Auditory; Hearing; Hearing Loss; Lateral Line System; Mice, Inbred C57BL; Mitochondria; NAD; Ototoxicity; Sirtuin 1; Zebrafish | 2021 |